现在是直言不讳的时候了:在囊性纤维化中使用药物
Sanaz Vaziri1, Meghan E McGarry1, Chiung-Yu Huang2
1Department of Pediatrics, University of California San Francisco, San Francisco, California, USA.
Pediatric pulmonology
|January 22, 2024
概括
包括大麻和CBD在内的物质使用在衰老的囊性纤维化患者中很常见. 医疗保健提供者应应对这些趋势以及这一群体对新药使用的潜在兴趣.
科学领域:
- 肺部病理学 肺部病理学
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
背景情况:
- 衰老的囊性纤维化 (CF) 患者群体面临着独特的挑战,包括物质使用.
- 有限的数据存在于大麻和大麻素 (CBD) 的使用,管理和原因在CF (pwCF) 患者中.
研究的目的:
- 在pwCF中调查大麻,CBD,电子烟和香烟的使用率.
- 为了比较物质使用者和非使用者之间的人口统计数据,疾病严重程度和CFTR调节器使用情况.
主要方法:
- 使用一次性电子调查进行的横截面研究.
- 在13岁以上的pwCF中评估物质使用.
- 通过后勤回归分析了物质使用,人口统计和CFTR调节器使用之间的关联.
主要成果:
- 在过去的一年中,29%的人使用大麻,22%的人使用CBD,27%的人使用电子烟,22%的人使用香烟.
- 吸毒者更有可能是大学毕业生或29-39岁.
- 电子烟和大麻使用者使用CFTR调节器的可能性增加;使用CBD,电子烟和香烟的人患精神健康查异常的比例更高.
结论:
- 药物使用在CF患者中比以前认为的更为普遍.
- 医疗保健提供者必须在这个日益增长的人口中解决物质使用问题.
- 显著比例的非使用者表示有兴趣尝试大麻和CBD.
相关概念视频
Cystic Fibrosis: Management
164
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
164
Cystic Fibrosis: Pathogenesis
244
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
244
Substance Use Disorders Affecting Sleep
168
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
168
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
288
Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
288
Drugs for Treatment of Constipation-Predominant IBS
170
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
170
Pulmonary Tuberculosis I
243
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
243


